Results 111 to 120 of about 5,736 (160)

Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle. [PDF]

open access: yesNat Commun
Kumarasamy V   +15 more
europepmc   +1 more source

Investigation of X-rays Beams Uniformity in Radiotherapeutic Tumor Treatment Procedure Using LuAG:Ce Crystal Detectors. [PDF]

open access: yesMaterials (Basel)
Witkiewicz-Łukaszek S   +5 more
europepmc   +1 more source

Real-World Experience among Elderly Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitor-Based Therapy. [PDF]

open access: yesCancers (Basel)
O'Connor TN   +6 more
europepmc   +1 more source

Cu(ii) binding to an antimicrobial shrimp peptide - a small step for structural chemistry, a big leap for medicinal applications. [PDF]

open access: yesChem Sci
Miller A   +9 more
europepmc   +1 more source

Acquired resistance in cancer: towards targeted therapeutic strategies. [PDF]

open access: yesNat Rev Cancer
Soragni A   +23 more
europepmc   +1 more source

Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression. [PDF]

open access: yesCancer Discov
Ye J   +18 more
europepmc   +1 more source

Cancer takes many paths through G1/S. [PDF]

open access: yesTrends Cell Biol
Knudsen ES, Witkiewicz AK, Rubin SM.
europepmc   +1 more source

The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer. [PDF]

open access: yesCancer Res
Kumarasamy V   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy